Ekso Bionics Holdings Inc
(EKSO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,470 | -17,894 | -9,416 | -3,651 | -19,590 |
| Depreciation Amortization | 1,819 | 1,354 | 890 | 431 | 896 |
| Accounts receivable | 140 | -131 | 503 | -314 | -577 |
| Accounts payable and accrued liabilities | -818 | -1,335 | -620 | 924 | 1,738 |
| Other Working Capital | -2,164 | -3,537 | -3,058 | -2,158 | 621 |
| Other Operating Activity | -504 | 988 | -2,421 | -2,021 | -1,357 |
| Operating Cash Flow | $-24,997 | $-20,555 | $-14,122 | $-6,789 | $-18,269 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,096 | -728 | -597 | -285 | -1,492 |
| Investing Cash Flow | $-1,096 | $-728 | $-597 | $-285 | $-1,492 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,930 | N/A | N/A | N/A | N/A |
| Debt Repayment | -79 | -58 | -56 | -19 | -60 |
| Common Stock Issued | 16,629 | 14,768 | 57 | 28 | 278 |
| Other Financing Activity | -173 | -173 | -173 | -173 | 13,906 |
| Financing Cash Flow | $23,307 | $14,537 | $-172 | $-164 | $14,124 |
| Exchange Rate Effect | 80 | -6 | 0 | N/A | -1 |
| Beginning Cash Position | 19,552 | 19,552 | 19,552 | 19,552 | 25,190 |
| End Cash Position | 16,846 | 12,800 | 4,661 | 12,314 | 19,552 |
| Net Cash Flow | $-2,706 | $-6,752 | $-14,891 | $-7,238 | $-5,638 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,997 | -20,555 | -14,122 | -6,789 | -18,269 |
| Capital Expenditure | -1,096 | -728 | -597 | -285 | -1,492 |
| Free Cash Flow | -26,093 | -21,283 | -14,719 | -7,074 | -19,761 |